To help healthcare systems plan for the future, it is important to forecast the requirement for resources. There are an estimated 10 million people around the world with Parkinson’s disease, and as the fastest growing neurodegenerative condition this is set to increase.3,4 The analysis on the slide using data from 2017 estimated that a total of 1.04 million people were diagnosed with PD in the US, with an annual cost of approximately $50 billion, including $25 billion direct costs.1 By the year 2037, this total cost was predicted to increase to $79 billion, corresponding to a predicted 1.6 million people with PD.1 Previous analyses may have underestimated how the cost of PD may increase in the future, in the absence of effective preventative interventions.1,2
2.Dorsey ER, Bloem BR. The Parkinson pandemic – a call to action. JAMA Neurol; 75 (1): 9–10.
3.Parkinson’s Foundation website. Available at: https://www.parkinson.org/understanding-parkinsons/statistics. Accessed November 2024.
4.Parkinson’s Europe website. Available at: https://parkinsonseurope.org/facts-and-figures/statistics/. Accessed November 2024.